Neuron-Specific Enolase (NSE) LIS Code: NSE
Measure neuron-specific enolase with a private blood test for neuroendocrine tumour assessment.
Test Categories
About this test
Understanding Neuron-Specific Enolase (NSE)
Neuron-specific enolase (NSE) is a key tumour marker primarily used in the monitoring of small cell bronchial carcinoma. Its presence in the blood is closely associated with neuroendocrine tumours, making it a valuable tool for disease tracking and treatment response.
CYFRA 21-1 and Non-Small Cell Lung Carcinoma
CYFRA 21‑1 is considered a more reliable marker than NSE when it comes to non-small cell bronchial carcinoma. This marker is derived from fragments of cytokeratin 19 and is particularly effective in identifying epithelial cell-related lung cancers.
Lung Cancer Marker Testing in Slough and Nearby Areas
Private blood testing for tumour markers such as NSE and CYFRA 21‑1 is available in Slough, Windsor, Maidenhead, and surrounding Berkshire areas. These tests support early diagnosis, monitoring, and management of lung cancer for patients seeking fast and reliable clinical insight.
